← Back to headlines
Vir Biotechnology GAAP EPS of -$0.31 beats by $0.10, revenue of $64.07M beats by $44.16M
Vir Biotechnology announced its fourth-quarter financial results, reporting a GAAP EPS of -$0.31, beating estimates by $0.10, and revenue of $64.07 million, surpassing estimates by $44.16 million.
23 Feb, 22:18 — 23 Feb, 22:18
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
China leaves benchmark lending rates unchanged as Beijing signals tolerance for stronger yuan
21m ago
Binance Fired Staff Over Iran Sanctions Violations
25m ago
Keysight Reports Strong Q2 Revenue and EPS Growth Driven by AI and Defense Demand
30m ago
From Rs 47 crore PAT to Rs 252 crore in 3 quarters: Is CreditAccess Grameen’s worst behind it?
35m ago